Benzinga

Benzinga

Benzinga

venerdì, agosto 21

West Pharmaceutical Services Inc

WSTNYSE
Trade with Public
Trade with Public
$353.08
-0.69-0.2%
In chiusura: Aug 21, 5:00 PM EST
$353.08
N/A
Post-mercato: 4:00 PM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaOpzioniRapporto azionario

West Pharmaceutical Servs Analyst Price Targets

Wall Street analyst price targets and consensus rating for West Pharmaceutical Servs (WST).

Price Target Range — 11 Quarters

Analyst Consensus — 12 Analysts

12Buy
Consensus RatingBuy# Analysts12Avg. Consensus PT$393Upside to Avg. PT+11.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 3, 2026CitigroupJoanne WuenschPT RaiseBuy$400→$412
Jul 27, 2026Evercore ISI GroupDaniel MarkowitzPT RaiseOutperform$410→$425
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412

Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $400 to $412.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $425

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $410 to $425.
Benzinga Newsdesk

PRO
BNP Paribas Initiates Coverage On West Pharmaceutical Servs with Outperform Rating, Announces Price Target of $447

BNP Paribas analyst Curtis Moiles initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Outperform rating and announces Price Target of $447.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $365

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $325 to $365.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $410

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $390 to $410.
Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $390

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $350 to $390.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved